# Multi-Center Study of New Medications to Treat Vaginal Infections

> **NCT02308046** · PHASE3 · COMPLETED · sponsor: **Curatek Pharmaceuticals, LLC** · enrollment: 212 (actual)

## Conditions studied

- Vaginal Infection

## Interventions

- **DRUG:** Terconazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02308046
- **Lead sponsor:** Curatek Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02308046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02308046, "Multi-Center Study of New Medications to Treat Vaginal Infections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02308046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*